RNA vaccines: The dawn of a new age for tuberculosis?

Abstract excerpt

Since 2019, there has been a growing focus on mRNA vaccines for infectious disease prevention, particularly following the emergence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). mRNA vaccines offer advantages such as rapid production and the ability to induce robust cellular and antibody responses, which are essential for combating infections that require cell-mediated immunity, including...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Tuberculosis Research and Epidemiology
• Share to Viral gastroenteritis research and epidemiology
• Share to Viral Infections and Immunology Research